A detailed history of Tfc Financial Management transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Tfc Financial Management holds 100 shares of SAGE stock, worth $548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 101 0.99%
Holding current value
$548
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$7.02 - $13.08 $7 - $13
-1 Reduced 0.99%
100 $0
Q2 2024

Jul 23, 2024

BUY
$10.58 - $17.9 $1,068 - $1,807
101 New
101 $1,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Tfc Financial Management Portfolio

Follow Tfc Financial Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.